SEC Form 4 · accession 0001209191-15-062432

KYNTRA BIO, INC. · KYNB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Executive Officer · Director · 10% Owner

Period of report

Jul 22, 2015

Accepted (ET)

Jul 24, 2015 · 6:26 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000921299

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Jul 22, 2015	S	13,500	$24.62	D	3,875,719	D
Common Stock	Jul 22, 2015	M	9,469	$2.35	A	3,885,188	D
Common Stock^F1,F3	Jul 23, 2015	S	13,500	$24.80	D	3,871,688	D
Common Stock	Jul 23, 2015	M	9,469	$2.35	A	3,881,157	D
Common Stock	holding	—	—		—	145,070	I	By Family Partnership
Common Stock	holding	—	—		—	20,000	I	By Spouse
Common Stock^F4	holding	—	—		—	60,946	I	See footnote

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F5	$2.35	Jul 22, 2015	M	9,469	D	—	Mar 12, 2018	Common Stock	9,469	352,655	D
Stock Option (Right to Buy)^F5	$2.35	Jul 23, 2015	M	9,469	D	—	Mar 12, 2018	Common Stock	9,469	343,186	D

F1Shares sold pursuant to a 10b5-1 plan.
F2The shares were sold at prices ranging from $24.29 to $24.95. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3The shares were sold at prices ranging from $24.46 to $25.00. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4The shares are held by BioGrowth Partners, LP. The reporting person is the sole general partner of BioGrowth Partners, LP and has sole voting and dispositive power over the shares held by BioGrowth Partners, LP.
F5Fully vested.